期刊文献+

奥美拉唑、克拉霉素、阿莫西林三联疗法根除幽门螺杆菌临床观察 被引量:2

下载PDF
导出
摘要 目的分析奥美拉唑、克拉霉素、阿莫西林三联疗法根除幽门螺杆菌的临床效果。方法将2010年4月~2011年4月于我院治疗的92例因幽门螺杆菌导致的消化性溃疡患者,按照随机分组法分成两组,各46例,观察组服用奥美拉唑20mg,克拉霉素500mg,阿莫西林1000mg;对照组服用奥美拉唑20mg,1~2次,持续服用30d。疗程结束一个月后进行复查并检测Hp,对比观察两组疗效和复发率。结果观察组有效41例(89.13%),对照组有效34例(73.91%),两者差异具有统计学意义(P<0.05)。观察组复发5例(10.86%),对照组21例(45.65%),差异显著(P<0.05)。结论奥美拉唑三联疗法是一种疗效好、复发率低的治疗方法。
作者 汪生华
出处 《中国卫生产业》 2012年第19期73-73,共1页 China Health Industry
  • 相关文献

参考文献3

二级参考文献8

  • 1Parente F,Maconi G,Sangaletti O,et al.Behaviour of acid secretion,gastrin release,serum pepsinogen I,and gastric emptying of liquids over six months from eradication of helicobacter pylori in duodenal ulcer patients:a controlled study[J].Gut,1995,37:210-2
  • 2Sepuulveda A,Peterson LE,Shelton J,et al.Histological patterns of gastritis in H.pylori-infected individuals with a family history of gastric cancer[J].Am J Gastroenterol,2002,97:1365-1370.
  • 3Ching CK,Lam SK.Helicobacter pylori epidemiology in realation to peptic ulcer and gastric cancer in South and North China[J].J Gastroenterol Hepatol,1994,9:4-7.
  • 4Go MF,Graham DY.How does helicobacter pylori causes duoidenal ulcer disease:the bug,the host,or both[J].J Gastroenterol hepatol,1994,9(Suppl):8-12.
  • 5EL-Omar,Penman ID,Ardill JES,et al.Chittajallu RS,Howie C,McColl KEL.Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease[J].Gastroenterol,1995,109:681-691.
  • 6Ohkusa T,Fujiki K,Takashimizu I,et al.Improvement in atrophic gastritis and intetinal metaplasia in patients in whom Helicobacter pylori was eradicated[J].Ann Intern Med 2001,134:380-386.
  • 7姚永莉,张万岱.幽门螺杆菌致病因子研究进展[J].世界华人消化杂志,2002,10(4):455-458. 被引量:40
  • 8王永福,孙春梅,耿立霞,许贤智,杨国安,陈鹏.幽门螺杆菌感染与胃黏膜病理改变的关系[J].中国临床医学,2004,11(1):48-50. 被引量:11

共引文献112

同被引文献32

  • 1黄玉芳,郑樨年,何元惠,丁金芳,李毓隽,袁晓琦.脾虚证胃痛及实证胃痛幽门弯曲菌与病变关系的研究[J].南京中医学院学报,1989,5(3):32-34. 被引量:25
  • 2李国锐.中医病症诊断疗效标准[M].南京:南京大学出版社,1994:201.
  • 3范竹萍,丁佳.幽门螺杆菌的治疗现状与进展[J].世界临床药物,2007,28(12):724-728. 被引量:15
  • 4郑筱萸.2002中药新药临床应用指导原则[M].北京:中国医药科技出版社,2002:153.
  • 5Ciacci C, Mazzacca G. The history of Helicobacter pylori: A reflection on the relationship between the medical com- munity and industry[J]. Dig Liver Dis,2006,38(10):778- 780.
  • 6Yan X,Zhou L,Song Z,et al. Sequential therapy for HP in adults compared with trip therapy in china:A mutleple- center,prospective,randomized,controlled trial(abstace) [J]. Helicobacter,2011,16(suppl 1 ) : 87.
  • 7Chang CH,Huang WY, Lai CH,et al. Development ofnovel nanoparticles shelled with heparin for berberine delivery to treat Helicobaeter pylori[J]. Aeta Biomater,2011, 7 (2) : 593 -603.
  • 8Jafri Nadim S,Hornung Carlton A,Howden Colin W.Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment. Annals of Internal Medicine . 2008
  • 9邵龙刚,顾勤.中药抑杀幽门螺杆菌研究进展[J].实用中医药杂志,2009,25(2):120-121. 被引量:21
  • 10张万岱,胡伏莲,萧树东,徐智民.中国自然人群幽门螺杆菌感染的流行病学调查[J].现代消化及介入诊疗,2010,15(5):265-270. 被引量:963

引证文献2

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部